Evidence map›Paper›PMID 37431406›Full record

ArticleJCPP advances2021

Group-based Acceptance and Commitment Therapy (AHEAD) for adolescents with multiple functional somatic syndromes: A randomised trial.

Karen Hansen Kallesøe, Andreas Schröder, Jens Søndergaard Jensen, Rikard K Wicksell, Charlotte Ulrikka Rask

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in JCPP advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02346071 nacompletednot on this map

Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes: Randomized Trial

TypeinterventionalSponsorUniversity of AarhusRan2015 to 2019Enrolled91ConditionsSomatization Disorder, Somatoform DisordersArmsAcceptance and Commitment Therapy, Enhanced Usual Care (EUC)
NCT06232473 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Efficacy of Patient Education and Duloxetine, Alone or in Combination, for Patients With Multisystem Functional Somatic Disorder

TypeinterventionalSponsorAarhus University HospitalRan2024 to 2029Enrolled424ConditionsFunctional DisorderArmsPatient Education, Duloxetine, Benztropine Mesylate 0.5 MG and passive placebo RAP, Enhanced usual care
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Beyond theJCPP advances · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Karen Hansen KallesøeThe Research Clinic for Functional Disorders and Psychosomatics Aarhus University Hospital Aarhus C Denmark.ORCID https://orcid.org/0000-0002-2413-4586
Andreas SchröderThe Research Clinic for Functional Disorders and Psychosomatics Aarhus University Hospital Aarhus C Denmark.
Jens Søndergaard JensenThe Research Clinic for Functional Disorders and Psychosomatics Aarhus University Hospital Aarhus C Denmark.
Rikard K WicksellDepartment of Clinical Neuroscience Karolinska Institutet Stockholm Sweden.
Charlotte Ulrikka RaskDepartment of Clinical Medicine Aarhus University Aarhus N Denmark.
Aarhus University · DKAarhus University Hospital · DKKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence for treatment of adolescents with multiple functional somatic syndromes (FSS) is sparse. This study examined the efficacy of 'Acceptance and Commitment Therapy for Health in Adolescents' (AHEAD), a generic group-based treatment for adolescents with co-occurrence of multiple FSS. Methods: A randomized trial was conducted at a specialized university hospital clinic. Adolescents (15-19 years) with multiple FSS of at least 1 year's duration were randomly assigned to AHEAD or enhanced usual care (EUC). AHEAD consisted of nine modules (i.e., 27 h) and one follow-up meeting. Primary outcome was physical health (SF-36). Various secondary outcomes and treatment targets were included (e.g., symptom severity, symptom impact, and illness perception). A linear mixed-effects model was used for analysis. Trial-registration: ClinicalTrials.gov NCT02346071. Results: Ninety-one patients were included. At 12 months, no significant difference in physical health was identified between groups (mean adjusted difference 1.2 [95% CI -1.6 to 4.0], Conclusions: Compared with EUC, AHEAD had no additional advantage on the improvement of physical health at the primary endpoint of 12 months. However, a faster improvement of physical health was seen in AHEAD and considerably more psychological treatment was received outside the trial in EUC with clinically meaningful improvements in both groups. The results underpin the importance of an organised and systematic treatment offer for the most severely affected youth.

Indexed as

Acceptance and Commitment Therapyadolescentsfunctional somatic syndromesgroup‐based therapyrandomised controlled trial

Identifiers

PMID37431406
PMCPMC10242822
OpenAlexW4200322527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.